The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AGILE THERAPEUTICS INC COM 00847L100 200 27,415 SH   SOLE   27,415 0 0
CELATOR PHARMACEUTICALS INC COM 15089R102 5,684 2,246,469 SH   SOLE   2,246,469 0 0
COVIDIEN PLC SHS G2554F113 379 4,381 SH   SOLE   4,381 0 0
SYNTA PHARMACEUTICALS CORP COM 87162T206 90,887 30,194,898 SH   SOLE   30,194,898 0 0